Development of TLM-007 as a myopia-suppression drug
An individual development theme focused on advancing TLM-007, a myopia-suppression drug developed through the expansion of indications for glaucoma eye drops, from basic research through specified clinical research in Japan.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.